About faricimab
Bispecific antibody; VEGF-A and angiopoietin-2 inhibitor
Used for
- Wet age-related macular degeneration
- Diabetic macular edema
- Macular edema after retinal vein occlusion
Usual adult dose
Eye specialist injects 6 mg into the affected eye, usually every 4 weeks initially; intervals may later extend to 8–16 weeks.
Common side effects
- Cataract
- Conjunctival bleeding
- Eye pain or irritation
- Increased eye pressure
Important warnings
- Eye injections can rarely cause infection, inflammation, retinal detachment, or severe vision loss.
- Seek urgent assessment for sudden vision changes, worsening eye pain, or increasing redness.
- Can increase eye pressure shortly after injection.
- Use caution with recent stroke, heart attack, or other arterial blood clots.
Pregnancy
Potential fetal risk is uncertain; pregnancy is generally avoided during treatment and for at least 3 months after the last dose.
Breastfeeding
Effects on breast milk and infants are unknown; discuss risks with a healthcare professional.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.